Welcome to LookChem.com Sign In|Join Free

CAS

  • or

644-62-2

Post Buying Request

644-62-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

644-62-2 Usage

Chemical Properties

White Crystalline Solid

Originator

Meclomen,Warner Lambert,US,1980

Uses

Meclofenamic acid is used for the same conditions as flufenamic acid.

Definition

ChEBI: An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoe (painful periods), osteoarthritis and rheumatoid arthritis.

Manufacturing Process

A mixture consisting of 22.7 g potassium o-bromobenzoate, 16.6 g 2,6- dichloro-3-methylaniline, 12 ml N-ethylmorpholine, 60 ml diethylene glycol dimethyl ether, and 1.0 g anhydrous cupric bromide is heated in a nitrogen atmosphere at 145°C to 155°C for 2 hours. The reaction mixture is diluted with 60 ml diethylene glycol dimethyl ether and acidified with 25 ml concentrated hydrochloric acid. The acidic mixture is diluted with 100 ml of water and the liquid phase decanted from the insoluble oil. The insoluble oil is stirred with methanol and the crystalline N-(2,6-dichloro-3-methylphenyl) anthranilic acid which separates is collected and washed with methanol. The product, after recrystallization from acetone-water mixture, melts at 248°C to 250°C.

Brand name

Meclomen (Parke-Davis).

Therapeutic Function

Antiinflammatory

Synthesis

Meclofenamic acid, N-(2,6-dichloro-m-tolyl)anthranylic acid (3.2.20), is synthesized analogous to flufenamic acid, by the reaction of potassium salt of 2-bromobenzoic acid with 2,6-dichloro-3-methylaniline in the presence of copper (II) bromide in a mixture of N-ethylmorpholine and diglyme [82,83].

Check Digit Verification of cas no

The CAS Registry Mumber 644-62-2 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,4 and 4 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 644-62:
(5*6)+(4*4)+(3*4)+(2*6)+(1*2)=72
72 % 10 = 2
So 644-62-2 is a valid CAS Registry Number.
InChI:InChI=1/C14H11Cl2NO2.Na/c1-8-6-7-10(15)13(12(8)16)17-11-5-3-2-4-9(11)14(18)19;/h2-7,17H,1H3,(H,18,19);/q;+1/p-1

644-62-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name meclofenamic acid

1.2 Other means of identification

Product number -
Other names 2-(2,6-dichloro-3-methylanilino)benzoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:644-62-2 SDS

644-62-2Synthetic route

2,6-dichloro-3-methylaniline
64063-37-2

2,6-dichloro-3-methylaniline

Diphenyliodonium-2-carboxylate
1488-42-2

Diphenyliodonium-2-carboxylate

MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

Conditions
ConditionsYield
With copper diacetate70%
With copper diacetate In isopropyl alcohol for 20h; Heating;0.9 g
2,6-dichloro-3-methylaniline
64063-37-2

2,6-dichloro-3-methylaniline

ortho-chlorobenzoic acid
118-91-2

ortho-chlorobenzoic acid

MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

Conditions
ConditionsYield
With potassium carbonate; copper In N,N-dimethyl-formamide for 2h; Heating;18%
2,6-dichloro-3-methylaniline
64063-37-2

2,6-dichloro-3-methylaniline

potassium 2-bromobenzoate
16497-87-3

potassium 2-bromobenzoate

MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

Conditions
ConditionsYield
With N-ethylmorpholine;; copper diacetate In N,N-dimethyl-formamide at 145℃; for 3h;
1,3-bis-(2,6-dichloro-3-methyl-phenyl)-1H-quinazoline-2,4-dione
13625-29-1

1,3-bis-(2,6-dichloro-3-methyl-phenyl)-1H-quinazoline-2,4-dione

MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

Conditions
ConditionsYield
With potassium hydroxide In ethylene glycol
2-[(2,6-dichloro-3-methylphenyl)amino]benzoic acid,methyl ester
3254-79-3

2-[(2,6-dichloro-3-methylphenyl)amino]benzoic acid,methyl ester

MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

Conditions
ConditionsYield
With hydrazine hydrate In methanol
With hydrazine hydrate In methanol
2,6-dichloro-3-methylaniline
64063-37-2

2,6-dichloro-3-methylaniline

o-fluoro-benzoic acid
445-29-4

o-fluoro-benzoic acid

MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

Conditions
ConditionsYield
With hydrogenchloride In monoethylene glycol diethyl ether
meclofenamate sodium
6385-02-0

meclofenamate sodium

MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

Conditions
ConditionsYield
With hydrogenchloride In water
meclofenamic acid ethyl ester

meclofenamic acid ethyl ester

MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

Conditions
ConditionsYield
With water; sodium hydroxide In tetrahydrofuran; ethanol
1-Adamantanamine
768-94-5

1-Adamantanamine

MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

C10H17N*C14H11Cl2NO2

C10H17N*C14H11Cl2NO2

Conditions
ConditionsYield
In methanol at 20℃;100%
oxalyl dichloride
79-37-8

oxalyl dichloride

MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

2-[(2,6-dichloro-3-methylphenyl)amino]benzoic acid,methyl ester
3254-79-3

2-[(2,6-dichloro-3-methylphenyl)amino]benzoic acid,methyl ester

Conditions
ConditionsYield
In N-methyl-acetamide; methanol; dichloromethane94%
89%
thianthrene-5-oxide
2362-50-7

thianthrene-5-oxide

MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

trifluoroacetic anhydride
407-25-0

trifluoroacetic anhydride

C26H18Cl2NO2S2(1+)*C2F3O2(1-)

C26H18Cl2NO2S2(1+)*C2F3O2(1-)

Conditions
ConditionsYield
With Thianthrene In acetonitrile at -78 - 25℃;87%
MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

acetic acid
64-19-7

acetic acid

N-(2-(diethylamino)ethyl)-2-[(2,6-dichloro-3-methylphenyl)amino]benzamide acetate

N-(2-(diethylamino)ethyl)-2-[(2,6-dichloro-3-methylphenyl)amino]benzamide acetate

Conditions
ConditionsYield
Stage #1: MECLOFENAMIC ACID; N,N-diethylethylenediamine With dicyclohexyl-carbodiimide In chloroform at 20℃; for 3h;
Stage #2: acetic acid In chloroform
85.8%
MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

2-(2,6-dichloro-3-methylphenylamino)benzohydrazide

2-(2,6-dichloro-3-methylphenylamino)benzohydrazide

Conditions
ConditionsYield
With hydrazine hydrate at 250℃; under 12929 Torr; for 0.0833333h; Microwave irradiation; Neat (no solvent);85%
MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

methyl 2-aminobutanoate hydrochloride
7682-18-0

methyl 2-aminobutanoate hydrochloride

(RS)-methyl 2-[2-(2,6-dichloro-3-methylphenylamino)benzamido]butanoate

(RS)-methyl 2-[2-(2,6-dichloro-3-methylphenylamino)benzamido]butanoate

Conditions
ConditionsYield
Stage #1: MECLOFENAMIC ACID With dicyclohexyl-carbodiimide In dichloromethane for 0.5h;
Stage #2: methyl 2-aminobutanoate hydrochloride With triethylamine In dichloromethane at 0 - 20℃;
77%
Stage #1: MECLOFENAMIC ACID With dicyclohexyl-carbodiimide In dichloromethane for 0.5h;
Stage #2: methyl 2-aminobutanoate hydrochloride With triethylamine In dichloromethane at 0 - 20℃;
62%
MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

3,4-dichlorobenzyl amine
102-49-8

3,4-dichlorobenzyl amine

N-(3,4-dichlorobenzyl)-2-(2,6-dichloro-3-methylphenylamino)-benzamide

N-(3,4-dichlorobenzyl)-2-(2,6-dichloro-3-methylphenylamino)-benzamide

Conditions
ConditionsYield
Stage #1: MECLOFENAMIC ACID With bis-(2-oxo-3-oxazolidinyl)phosphoryl chloride; triethylamine In dichloromethane at 20℃; for 0.0833333h;
Stage #2: 3,4-dichlorobenzyl amine In dichloromethane at 20℃;
70%
(R)-2-Phenoxy-1-propylamine
6437-49-6

(R)-2-Phenoxy-1-propylamine

MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

2-(2,6-dichloro-3-methyl-phenylamino)-N-(2-phenoxy-propyl)-benzamide

2-(2,6-dichloro-3-methyl-phenylamino)-N-(2-phenoxy-propyl)-benzamide

Conditions
ConditionsYield
Stage #1: MECLOFENAMIC ACID With bis-(2-oxo-3-oxazolidinyl)phosphoryl chloride; triethylamine In dichloromethane at 20℃; for 0.0833333h;
Stage #2: (R)-2-Phenoxy-1-propylamine In dichloromethane at 20℃;
70%
MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

cyclohexylamine
108-91-8

cyclohexylamine

N-cyclohexyl-2-(2,6-dichloro-3-methylphenylamino)-benzamide

N-cyclohexyl-2-(2,6-dichloro-3-methylphenylamino)-benzamide

Conditions
ConditionsYield
Stage #1: MECLOFENAMIC ACID With bis-(2-oxo-3-oxazolidinyl)phosphoryl chloride; triethylamine In dichloromethane at 20℃; for 0.0833333h;
Stage #2: cyclohexylamine In dichloromethane at 20℃;
68%
MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

methyl (L)-leucinate hydrochloride
7517-19-3

methyl (L)-leucinate hydrochloride

(S)-methyl 2-[2-(2,6-dichloro-3-methylphenylamino)benzamido]-4-methylpentanoate

(S)-methyl 2-[2-(2,6-dichloro-3-methylphenylamino)benzamido]-4-methylpentanoate

Conditions
ConditionsYield
Stage #1: MECLOFENAMIC ACID With dicyclohexyl-carbodiimide In dichloromethane for 0.5h;
Stage #2: methyl (L)-leucinate hydrochloride With triethylamine In dichloromethane at 0 - 20℃;
67%
MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

glycine ethyl ester hydrochloride
623-33-6

glycine ethyl ester hydrochloride

ethyl 2-[2-(2,6-dichloro-3-methylphenylamino)benzamido]acetate

ethyl 2-[2-(2,6-dichloro-3-methylphenylamino)benzamido]acetate

Conditions
ConditionsYield
Stage #1: MECLOFENAMIC ACID With dicyclohexyl-carbodiimide In dichloromethane for 0.5h;
Stage #2: glycine ethyl ester hydrochloride With triethylamine In dichloromethane at 0 - 20℃;
67%
MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

4-chlorobenzylamine
104-86-9

4-chlorobenzylamine

N-(4-chlorobenzyl)-2-(2,6-dichloro-3-methylphenylamino)-benzamide

N-(4-chlorobenzyl)-2-(2,6-dichloro-3-methylphenylamino)-benzamide

Conditions
ConditionsYield
Stage #1: MECLOFENAMIC ACID With bis-(2-oxo-3-oxazolidinyl)phosphoryl chloride; triethylamine In dichloromethane at 20℃; for 0.0833333h;
Stage #2: 4-chlorobenzylamine In dichloromethane at 20℃;
67%
MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

benzylamine
100-46-9

benzylamine

N-benzyl-2-(2,6-dichloro-3-methyl-phenylamino)-benzamide
1347886-86-5

N-benzyl-2-(2,6-dichloro-3-methyl-phenylamino)-benzamide

Conditions
ConditionsYield
Stage #1: MECLOFENAMIC ACID With bis-(2-oxo-3-oxazolidinyl)phosphoryl chloride; triethylamine In dichloromethane at 20℃; for 0.0833333h;
Stage #2: benzylamine In dichloromethane at 20℃;
65%
MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

L-alanine methyl ester hydrochloride
2491-20-5

L-alanine methyl ester hydrochloride

(S)-methyl 2-[2-(2,6-dichloro-3-methylphenylamino)benzamido]propanoate

(S)-methyl 2-[2-(2,6-dichloro-3-methylphenylamino)benzamido]propanoate

Conditions
ConditionsYield
Stage #1: MECLOFENAMIC ACID With dicyclohexyl-carbodiimide In dichloromethane for 0.5h;
Stage #2: L-alanine methyl ester hydrochloride With triethylamine In dichloromethane at 0 - 20℃;
63%
lead(II) nitrate

lead(II) nitrate

MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

catena-poly[bis[μ2-2-((2,6-dichloro-3-methylphenyl)amino)benzoate-κ2O,O']lead(II)]

catena-poly[bis[μ2-2-((2,6-dichloro-3-methylphenyl)amino)benzoate-κ2O,O']lead(II)]

Conditions
ConditionsYield
In methanol; water for 1.5h;57%
MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

L-leucine ethyl ester hydrochloride
2743-40-0

L-leucine ethyl ester hydrochloride

(S)-ethyl 2-[2-(2,6-dichloro-3-methylphenylamino)benzamido]-4-methylpentanoate

(S)-ethyl 2-[2-(2,6-dichloro-3-methylphenylamino)benzamido]-4-methylpentanoate

Conditions
ConditionsYield
Stage #1: MECLOFENAMIC ACID With dicyclohexyl-carbodiimide In dichloromethane for 0.5h;
Stage #2: L-leucine ethyl ester hydrochloride With triethylamine In dichloromethane at 0 - 20℃;
52%
MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

S-benzyl-cysteine ethyl ester hydrochloride

S-benzyl-cysteine ethyl ester hydrochloride

ethyl 3-(benzylthio)-2-[2-(2,6-dichloro-3-methylphenylamino)benzamido]propanoate

ethyl 3-(benzylthio)-2-[2-(2,6-dichloro-3-methylphenylamino)benzamido]propanoate

Conditions
ConditionsYield
Stage #1: MECLOFENAMIC ACID With dicyclohexyl-carbodiimide In dichloromethane for 0.5h;
Stage #2: S-benzyl-cysteine ethyl ester hydrochloride With triethylamine In dichloromethane at 0 - 20℃;
51%
MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

L-Valine ethyl ester hydrochloride
17609-47-1

L-Valine ethyl ester hydrochloride

(S)-ethyl 2-[2-(2,6-dichloro-3-methylphenylamino)benzamido]-3-methylbutanoate

(S)-ethyl 2-[2-(2,6-dichloro-3-methylphenylamino)benzamido]-3-methylbutanoate

Conditions
ConditionsYield
Stage #1: MECLOFENAMIC ACID With dicyclohexyl-carbodiimide In dichloromethane for 0.5h;
Stage #2: L-Valine ethyl ester hydrochloride With triethylamine In dichloromethane at 0 - 20℃;
45%
MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

(L)-phenylalanine ethyl ester hydrochloride
3182-93-2

(L)-phenylalanine ethyl ester hydrochloride

(S)-ethyl 2-[2-(2,6-dichloro-3-methylphenylamino)benzamido]-3-phenyl propanoate

(S)-ethyl 2-[2-(2,6-dichloro-3-methylphenylamino)benzamido]-3-phenyl propanoate

Conditions
ConditionsYield
Stage #1: MECLOFENAMIC ACID With dicyclohexyl-carbodiimide In dichloromethane for 0.5h;
Stage #2: (L)-phenylalanine ethyl ester hydrochloride With triethylamine In dichloromethane at 0 - 20℃;
42%
MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

dimethyl L-aspartate hydrochloride
32213-95-9

dimethyl L-aspartate hydrochloride

(S)-dimethyl-2-[2-(2,6-dichloro-3-methylphenylamino)benzamido]succinate

(S)-dimethyl-2-[2-(2,6-dichloro-3-methylphenylamino)benzamido]succinate

Conditions
ConditionsYield
Stage #1: MECLOFENAMIC ACID With dicyclohexyl-carbodiimide In dichloromethane for 0.5h;
Stage #2: dimethyl L-aspartate hydrochloride With triethylamine In dichloromethane at 0 - 20℃;
39%
MECLOFENAMIC ACID
644-62-2

MECLOFENAMIC ACID

D-Valine methyl ester hydrochloride
7146-15-8

D-Valine methyl ester hydrochloride

(R)-methyl 2-[2-(2,6-dichloro-3-methylphenylamino)benzamido]-3-methylbutanoate

(R)-methyl 2-[2-(2,6-dichloro-3-methylphenylamino)benzamido]-3-methylbutanoate

Conditions
ConditionsYield
Stage #1: MECLOFENAMIC ACID With dicyclohexyl-carbodiimide In dichloromethane for 0.5h;
Stage #2: D-Valine methyl ester hydrochloride With triethylamine In dichloromethane at 0 - 20℃;
37%

644-62-2Relevant articles and documents

Synthesis, crystal structures and spectroscopy of meclofenamic acid and its metal complexes with manganese(II), copper(II), zinc(II) and cadmium(II). Antiproliferative and superoxide dismutase activity

Kovala-Demertzi, Dimitra,Staninska, Malgorzata,Garcia-Santos, Isabel,Castineiras, Alfonso,Demertzis, Mavroudis A.

, p. 1187 - 1195 (2011)

Some new complexes of meclofenamic acid (N-(2,6-dichloro-m-tolyl) anthranilic acid), Hmeclo (1), with potentially interesting biological activities are described. Complexes [Mn(meclo)2] (2), [Cu(meclo) 2(H2O)2] (3), [Zn(meclo)2(H 2O)2] (4) and [Cd(meclo)2(H2O) 2] (5) were prepared and structurally characterized by means of vibrational, electronic and 1H and 13C NMR spectroscopies. The crystal structure of complexes [Cu4(meclo)6(OH) 2(DMSO)2]2DMSO (3a) and [Cd(meclo)2(DMSO) 3] (5a) have been determined by X-ray crystallography. Complex (3a) is a centrosymmetric tetramer built up around the planar cyclic Cu 2(OH)2 unit. Complex 5a is mononuclear seven-coordinated complex with the meclofenamato ligand behaving as a bidentate deprotonated chelating ligand. Intra and intermolecular hydrogen bonds stabilize these two structures, while the crystal packing is determined by π-π and C-H - π interactions. Meclofenamic acid and its metal complexes have been evaluated for antiproliferative activity in vitro against the cells of three human cancer cell lines, MCF-7 (breast cancer cell line), T24 (bladder cancer cell line), and A-549 (non-small cell lung carcinoma), and a mouse fibroblast L-929 cell line. Complex 5 exhibits the highest selectivity against MCF-7 and 4 shows the highest selectivity against T-24. Complexes 2-5 were found to be more potent cytotoxic agents against T-24 and complex 5 against MCF-7 cancer cell lines than the prevalent benchmark metallodrug, cis-platin. The superoxide dismutase activity was measured by the Fridovich test which showed that complex [Cu(meclo) 2(H2O)2] is a good superoxide scavenger.

High solubility piperazine salts of the nonsteroidal anti-inflammatory drug (NSAID) meclofenamic acid

Sanphui, Palash,Bolla, Geetha,Nangia, Ashwini

body text, p. 2023 - 2036 (2012/06/30)

Meclofenamic acid (MFA) is the most potent anti-inflammatory drug among the fenamic acids. We report (1) two cocrystals of MFA with isonicotinamide (INA) and 4,4′-bipyridine (BPY); (2) polymorphs of MFA and piperazine (PPZ) 1:1 salt (orthorhombic P212121 O and monoclinic P21/c M), MFA-PPZ-H2O 1:1:1 salt hydrate, MFA-PPZ 2:1 salt; and (3) MFA and 2-aminopyridine (2-APY) 1:1 salt, MFA and 4-aminopyridine (4-APY) 1:1:1 salt hydrate. Sublimation of MFA gave single crystals for X-ray diffraction which provided good quality data for refinement and all atomic coordinates. The cocrystal and salt structures are assembled via neutral O-H???O, O-H???N, N-H???O, N-H???N, and ionic O-H???O-, N +-H???O- hydrogen bonds. The disorder of the methyl group in the MFA crystal structure is absent in the cocrystal and salt structures, which contain different conformers (A or B) of methyl group orientation. The solubility of MFA-INA (1:1) and MFA-BPY (1:0.5) cocrystals is 2.9 and 7.6 times higher than that of MFA at 37 °C in 50% EtOH-water. Interestingly, MFA-PPZ-M 1:1 salt and its 1:1:1 hydrate are 2724- and 1334-fold more soluble than MFA. Both of these salts transformed in 50% EtOH-water slurry at 37 °C to MFA-PPZ 2:1 salt after 24 h, which in turn transformed to MFA after another 24 h of slurry stirring. Remarkably, the dissolution rate of MFA-PPZ-M (1:1) salt in water is just slightly lower than that of the marketed sodium meclofenamate.

Methods for use of GABAa receptor GABAergic compounds

-

, (2008/06/13)

A method is disclosed for potentiating mammalian GABA A receptor responses to GABA. The receptor responses are potentiated according to the invention by contacting GABA A receptors with GABA and an effective amount of non-steroidal anti-inflammatory agents, in particular, fenamates and structurally related compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 644-62-2